In GD, GlcCer accumulation due to lysosomal β-glucocerebrosidase deficiency results in the persistent expression of tumor-associated macrophage markers (e.g., CD163), CD206-positive bone marrow mesenchymal stromal cells, and activated CD4+T cells. This evidence concerns the gene CD4 and neoplasm.